CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms of generalized anxiety disorder (GAD) in clinical trials. However, there is ...

The medication is related to ketamine ... with about one-third not responding to oral antidepressants alone.

Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

RFK Jr. says antidepressants could cause school shootings and are 'harder to get off' of than heroin. Experts say he's 'way off base.' ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.